Did K Conaway sell Regeneron Pharmaceuticals stock?

Common questions

Did K Conaway sell Regeneron Pharmaceuticals stock?

Yes. K Conaway disclosed 2 sales of Regeneron Pharmaceuticals (REGN) stock between Jan 28, 2016 and Feb 26, 2016, in STOCK Act reports. Added together, the disclosed ranges come to $2K-$30K.

How big were K Conaway's Regeneron Pharmaceuticals trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $2K-$30K.

Did K Conaway make these Regeneron Pharmaceuticals trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does K Conaway still own Regeneron Pharmaceuticals stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did K Conaway report these trades?

The latest filing is dated Mar 2, 2016. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.